SOX17 and cholangiocarcinoma: In vitro and in vivo assays have shown that restoration of SOX17, whose expression is markedly reduced in CCA compared to healthy cholangiocytes, decreases the activity of the Wnt/β-catenin pathway, reducing tumor proliferation and progression [56].